Table 1.
Parameters | Oral (50 mg/kg bw) | Intravenous (5 mg/kg bw) |
---|---|---|
Tmax (min) | 340.00 ± 48.99 | – |
Cmax (μg/mL) | 0.87 ± 0.33 | 1.07 ± 0.49 |
t1/2 (min) | 342.43 ± 71.27 | 69.87 ± 15.72 |
AUC (min · μg/mL) | 213.78 ± 80.63 | 78.85 ± 7.39 |
AUC/Dose (min/L) | 4.28 ± 1.61 | 15.77 ± 1.48 |
F (%) | 27.11 |
Data are expressed as mean ± SD from six rats. Cmax, peak plasma concentration (μg/mL plasma), tmax; time to reach Cmax; t1/2, elimination half-life; AUC0–24, area under the concentration–time curve; F, absolute oral bioavailability.